MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 24, 2008; DOI: 10.1124/mol.108.044834


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.044834v1
74/1/101    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFarland, M. J.
Right arrow Articles by Barker, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFarland, M. J.
Right arrow Articles by Barker, E.


Received for publication January 3, 2008.
Revised April 23, 2008.
Accepted for publication April 23, 2008.

RNAi-Mediated Knockdown of Dynamin 2 Reduces Endocannabinoid Uptake Into Neuronal dCAD Cells

Matthew J. McFarland 1, Tamera K. Bardell 1, Marla L. Yates 1, Ekaterina A. Placzek 1, Eric Barker 2*

1 Purdue University 2 Purdue University School of Pharmacy

* Address correspondence to: E-mail: ericb{at}pharmacy.purdue.edu

Abstract

The precise mechanism by which the cellular uptake of the endocannabinoid anandamide occurs has been the source of much debate. In the current study, we show that neuronal dCAD cells accumulate anandamide by a process that is inhibited in a dose-dependent manner by AM404. We also show that dCAD cells express functional fatty acid amide hydrolase (FAAH), the enzyme primarily responsible for anandamide metabolism. Previous data from our laboratory indicated that anandamide uptake occurs by a caveolae-related endocytic mechanism in RBL-2H3 cells. In the current study, we show that anandamide uptake by dCAD cells may also occur by an endocytic process that is associated with detergent-resistant membrane microdomains or lipid rafts. Nystatin and progesterone pretreatment of dCAD cells significantly inhibited anandamide accumulation. Furthermore, RNAi-mediated knockdown of dynamin 2, a protein involved in endocytosis, blocked the internalization of the fluorescently labeled anandamide analog SKM 4-45-1. RNAi-mediated knockdown of the {beta}2 subunit of the clathrin-associated AP2 complex had no effect on SKM 4-45-1 internalization. Surprisingly, dynamin 2 knockdown in dCAD cells did not affect [3H]AEA uptake. However, dynamin 2 knockdown caused a significant increase in the overall levels of intact [3H]AEA associated with the cells suggesting that trafficking of [3H]AEA to FAAH had been disrupted. This finding may be the result of an accumulation of the anandamide carrier protein in detergent-resistant membranes following dynamin 2 knockdown. Our studies provide evidence that the cellular uptake of anandamide may occur by a dynamin 2-dependent, caveolae-related endocytic process in dCAD cells.


Key words: Cannabinoid, Lipid rafts/microdomains, Fluorescence techniques, RNA/siRNA





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics